Skip to main content

Prefilled Syringes Market to Reach USD 10.57 Billion by 2026; Introduction of BD’s Disposable Autoinjector to Aid Expansion, states Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, July 16, 2020 (GLOBE NEWSWIRE) — The global prefilled syringes market size is expected to reach USD 10.57 billion by 2027, exhibiting a CAGR of 10.5% during the forecast period. The rising prevalence of diabetes can be a vital factor in favoring the growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Prefilled Syringes Market Size, Share & Covid-19 Impact Analysis, By Material (Glass and Plastic) By Closing System (Staked Needle System, Luer Cone System, and Luer Lock Form System) By Product (Complete Syringe Set and Components & Accessories); By Design (Double-chamber, Multiple-chamber, and Single-chamber); By End-user (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, and Others), and Regional Forecast, 2020-2027” the market size stood at USD 4.76 billion in 2019.The report on the prefilled syringes market covers:Wide-ranging study of all the sectionsRevealing data and figuresMarket trends and driversProjections on coronavirus crisisGrander insights into all emerging developmentsMarket Driver:Rising Cases of Chronic Diseases to Augment GrowthThe growing incidence of cancer and other non-communicable diseases is expected to spur demand for biological drugs, which, in turn, will foster the growth of the market. According to the National Cancer Institute, an estimated 1,735,530 new cancer cases were diagnosed in the U.S. in 2018. The number is expected to reach 23.6 million by 2030, thus, boosting the need for biologics. The rising shift towards prefilled syringes for the administration of biologics and biosimilars will have an excellent impact on the market during the forecast period. Similarly, the application of biologics in numerous target diseases with limited treatment options such as cancer, autoimmune diseases, and other non-communicable diseases will spur the demand of the market in the forthcoming years.The coronavirus occurrence has brought the world to an unexpected stop. We understand that this health emergency has adversely impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain during this global pandemic. 
Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946
The pharmaceutical packaging industry has witnessed a substantial effect due to the COVID-19 outbreak. The increasing clinical trials for coronavirus vaccines have resulted in the high production of other related drugs. The shift from conventional syringes to prefilled syringes owing to the reduced risks of needle-stick injuries and infection will boost its production during coronavirus. The US government has signed a deal of $138 million with the makers of the syringe in order to facilitate the production of 100 million prefilled syringes by the end of 2020 and more than 500 million in 2021. In addition, the increased production capacities of manufacturers amid coronavirus will enable speedy expansion of the market.Regional Analysis:Increasing Product Launches to Support Development in EuropeEurope is expected to witness a high growth rate during the forecast period owing to the increasing number of patients using biologics as treatment options for chronic diseases. The increasing adoption of prefilled syringes as self-injecting drug devices will further support the growth of the market in Europe. The presence of major players will boost growth in the region. Additionally, the growing introduction of a new prefilled syringe by major players will favor growth in the region.For instance, in October 2018, Fresenius Kabi announced the launch of a new prefilled syringe of palonosetron hydrochloride. North America is expected to rise tremendously during the forecast period owing to the surge in chronic diseases such as diabetes and rheumatoid arthritis. The strong distribution networks of eminent players will boost growth in North America. The market in Asia Pacific is likely to observe a significant growth rate owing to the increasing prevalence of chronic diseases and a rapidly growing patient population.October 2019: BD (Becton, Dickinson, and Company) announced the launch of the BD Intevia 1mL two-step disposable autoinjector. The innovative device combines autoinjector and pre-fillable syringe in one integrated system.List of the Leading Companies Profiled in the Prefilled Syringes Market Research Report are:BD (New Jersey, United States)Gerresheimer AG (Dusseldorf, Germany)SCHOTT AG (Mainz, Germany)West Pharmaceutical Services Inc. (Pennsylvania, United States)Helvoet Rubber & Plastic Technologies BV (Netherlands)Nipro Pharma Packaging International (Mechelen, Belgium)AptarGroup, Inc. (Illinois, United States)Terumo Corporation (Tokyo, Japan)Other Prominent PlayersIntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsRegulatory Scenario by Key Countries/Key RegionOverview of Secondary Prefilled Containers such as Auto-injectors, Pens, etc.Prefilled Syringes Key Market TrendsOverview of Contract Research and Manufacturing Service Providers for Prefilled SyringesKey Industry Developments (Mergers, Acquisitions, Strategic Partnerships, Collaborations, etc.)Global Prefilled Syringes Market Analysis, Insights and Forecast, 2016-2027Key Findings / SummaryMarket Analysis, Insights and Forecast – By MaterialGlassPlasticMarket Analysis, Insights and Forecast – By Closing SystemStaked Needle SystemLuer Cone SystemLuer Lock Form SystemMarket Analysis, Insights and Forecast – By ProductComplete Syringe SetComponents & Accessories (Backstops, Plunger Stoppers, and Plunger Rods)Market Analysis, Insights and Forecast – By DesignSingle-chamberDouble-chamberMultiple-chamberMarket Analysis, Insights and Forecast – By End UserMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaPharmaceutical & Biotechnology CompaniesContract Research & Manufacturing OrganizationsOthersTOC Continued…!!!

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/prefilled-syringes-market-101946
Injectable Drug Delivery Market Size, Share and Global Trend By Device Type (Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors, Others), By Application (Autoimmune Disorders, Diabetes, Pain Management, Aesthetic Treatments, Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, Others), By End-User (Hospitals, Home Care Settings, Clinics, Others) and Geography Forecast till 2026Diabetes Treatment Devices Market Size, Share and Global Trend By Product (Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others), By Distribution Channel (Institutional Sales (Hospitals, Clinics), Retail Sales (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)) & Geography Forecast till 2026U.S. Biosimilars Market Size, Share and Global Trend By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, Others), By Disease Indication (Cancer, Autoimmune Diseases, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026Human Insulin Market Size, Share & Industry Analysis, By Type (Analogue Insulin, Traditional Human Insulin), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Regional Forecast, 2019-2026Closed System Transfer Devices Market Size, Share and Global Trend By Type (Membrane-To-Membrane Systems, Needleless Systems), By Component (Vial Access Devices, Syringe Safety Device), By Closing Mechanism (Color to Color Alignment, Push toLock), By Technology (Diaphragm-Based Devices, Compartmentalized Devices), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and Geography Forecast till 2026

About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/prefilled-syringes-market-9503

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.